Trial Profile
Role of Inflammation Factors and Insulin Resistance in the Pathophysiology and Treatment Response of Major Depressive Disorder
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary) ; Valsartan (Primary)
- Indications Major depressive disorder
- Focus Biomarker; Therapeutic Use
- 12 Oct 2012 New trial record